Keyphrases
Affibody
27%
Allosteric Antagonism
13%
Basic Residues
13%
Cadherin
35%
Calcium Binding
25%
Calcium-dependent
21%
Cell Adhesion
22%
COX-2 Inhibitors
13%
Death Receptor 5
55%
Dimer Formation
32%
Dimeric Form
13%
Dimerization
69%
Drug Discovery
13%
E-cadherin
17%
Epithelial Cadherin
13%
Extracellular Domain
47%
Fast Assembly
13%
Fluorescence Lifetime Measurement
16%
High-throughput Screening
18%
Indirubin
13%
Induced Activation
13%
Induced Apoptosis
15%
Induced Strain
13%
Jurkat Cells
13%
MK886
13%
Modular Domain
13%
Monovalent Cations
13%
N-cadherin
63%
Neural Cadherin
96%
Neurite
13%
Nimesulide
13%
Non-competitive
27%
Pancreatic Cancer Cells
13%
PH Impact
13%
Proline
13%
Receptor-ligand Interaction
21%
Screening Approach
13%
Sequential Binding
13%
Sickle Cell Disease
13%
Sickle Hemoglobin
13%
Small Molecules
22%
Synapse
22%
TNF Receptor 1 (TNFR1)
51%
TNF Receptor 2 (TNFR2)
19%
TRAIL-induced Apoptosis
13%
Transmembrane Domain
13%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
17%
Tumor Necrosis Factor-α
24%
Zafirlukast
19%
τ-induced
13%
Biochemistry, Genetics and Molecular Biology
Affibody
27%
Amino Acids
5%
Anticancer
5%
Binding Affinity
6%
Binding Site
9%
C-Terminus
5%
Cadherin
100%
Calcium Binding
26%
Cancer Cell
13%
Caspase 8
9%
Cell Adhesion
16%
Cell Death
10%
Cell Membrane
7%
Conformation
8%
COX-2 Inhibitor
13%
Death Domain
6%
Denaturation
5%
Dimerization
78%
Dynamics
30%
Energy Transfer
9%
Fluorescence Resonance Energy Transfer
28%
High Throughput Screening
15%
L 663536
13%
Lifespan
5%
Ligand Binding
7%
N-Terminus
7%
Neural Cell Adhesion Molecule
57%
Oligomerization
7%
Programmed Cell Death
41%
Proline
13%
Sedimentation Rate
9%
Size-Exclusion Chromatography
6%
Small Molecule
19%
Synapse
31%
Tau
13%
TRAIL
34%
Transmembrane Domain
13%
Tryptophan
5%
Tumor Necrosis Factor
45%
Tumor Necrosis Factor Receptor
35%
Upregulation
7%
Wild Type
8%
Zafirlukast
19%
